These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 26851945)

  • 1. Genetic, Cellular and Clinical Features of ICF Syndrome: a French National Survey.
    Sterlin D; Velasco G; Moshous D; Touzot F; Mahlaoui N; Fischer A; Suarez F; Francastel C; Picard C
    J Clin Immunol; 2016 Feb; 36(2):149-59. PubMed ID: 26851945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Immunological Characterization of ICF Syndrome in Japan.
    Kamae C; Imai K; Kato T; Okano T; Honma K; Nakagawa N; Yeh TW; Noguchi E; Ohara A; Shigemura T; Takahashi H; Takakura S; Hayashi M; Honma A; Watanabe S; Shigemori T; Ohara O; Sasaki H; Kubota T; Morio T; Kanegane H; Nonoyama S
    J Clin Immunol; 2018 Nov; 38(8):927-937. PubMed ID: 30353301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the mutation spectrum in ICF syndrome: Evidence for a gender bias in ICF2.
    van den Boogaard ML; Thijssen PE; Aytekin C; Licciardi F; Kıykım AA; Spossito L; Dalm VASH; Driessen GJ; Kersseboom R; de Vries F; van Ostaijen-Ten Dam MM; Ikinciogullari A; Dogu F; Oleastro M; Bailardo E; Daxinger L; Nain E; Baris S; van Tol MJD; Weemaes C; van der Maarel SM
    Clin Genet; 2017 Oct; 92(4):380-387. PubMed ID: 28128455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel deletion in ZBTB24 in a Lebanese family with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2.
    Chouery E; Abou-Ghoch J; Corbani S; El Ali N; Korban R; Salem N; Castro C; Klayme S; Azoury-Abou Rjeily M; Khoury-Matar R; Debo G; Germanos-Haddad M; Delague V; Lefranc G; Mégarbané A
    Clin Genet; 2012 Nov; 82(5):489-93. PubMed ID: 21906047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous clinical presentation in ICF syndrome: correlation with underlying gene defects.
    Weemaes CM; van Tol MJ; Wang J; van Ostaijen-ten Dam MM; van Eggermond MC; Thijssen PE; Aytekin C; Brunetti-Pierri N; van der Burg M; Graham Davies E; Ferster A; Furthner D; Gimelli G; Gennery A; Kloeckener-Gruissem B; Meyn S; Powell C; Reisli I; Schuetz C; Schulz A; Shugar A; van den Elsen PJ; van der Maarel SM
    Eur J Hum Genet; 2013 Nov; 21(11):1219-25. PubMed ID: 23486536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF syndrome).
    Hagleitner MM; Lankester A; Maraschio P; Hultén M; Fryns JP; Schuetz C; Gimelli G; Davies EG; Gennery A; Belohradsky BH; de Groot R; Gerritsen EJ; Mattina T; Howard PJ; Fasth A; Reisli I; Furthner D; Slatter MA; Cant AJ; Cazzola G; van Dijken PJ; van Deuren M; de Greef JC; van der Maarel SM; Weemaes CM
    J Med Genet; 2008 Feb; 45(2):93-9. PubMed ID: 17893117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Clinical and Immunological Alterations Associated with ICF Syndrome.
    Bilgic Eltan S; Nain E; Catak MC; Ezen E; Sefer AP; Karimi N; Kiykim A; Kolukisa B; Baser D; Bulutoglu A; Kasap N; Yorgun Altunbas M; Yalcin Gungoren E; Kendir Demirkol Y; Kutlug S; Hancioglu G; Dilek F; Yildiran A; Ozen A; Karakoc-Aydiner E; Erman B; Baris S
    J Clin Immunol; 2023 Dec; 44(1):26. PubMed ID: 38129713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline genes hypomethylation and expression define a molecular signature in peripheral blood of ICF patients: implications for diagnosis and etiology.
    Velasco G; Walton EL; Sterlin D; Hédouin S; Nitta H; Ito Y; Fouyssac F; Mégarbané A; Sasaki H; Picard C; Francastel C
    Orphanet J Rare Dis; 2014 Apr; 9():56. PubMed ID: 24742017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation in ICF syndrome: evidence for genetic heterogeneity.
    Wijmenga C; Hansen RS; Gimelli G; Björck EJ; Davies EG; Valentine D; Belohradsky BH; van Dongen JJ; Smeets DF; van den Heuvel LP; Luyten JA; Strengman E; Weemaes C; Pearson PL
    Hum Mutat; 2000 Dec; 16(6):509-17. PubMed ID: 11102980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in ZBTB24 are associated with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2.
    de Greef JC; Wang J; Balog J; den Dunnen JT; Frants RR; Straasheijm KR; Aytekin C; van der Burg M; Duprez L; Ferster A; Gennery AR; Gimelli G; Reisli I; Schuetz C; Schulz A; Smeets DFCM; Sznajer Y; Wijmenga C; van Eggermond MC; van Ostaijen-Ten Dam MM; Lankester AC; van Tol MJD; van den Elsen PJ; Weemaes CM; van der Maarel SM
    Am J Hum Genet; 2011 Jun; 88(6):796-804. PubMed ID: 21596365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A young girl with hypogammaglobulinemia and granulomatous hepatitis caused by a novel mutation in ZBTB24 gene: A case based analysis.
    Banday AZ; Jindal AK; Kaur A; Kumar Y; Nameirakpam J; Patra PK; Rawat A
    Immunobiology; 2020 May; 225(3):151912. PubMed ID: 32061411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtelomeric methylation distinguishes between subtypes of Immunodeficiency, Centromeric instability and Facial anomalies syndrome.
    Toubiana S; Velasco G; Chityat A; Kaindl AM; Hershtig N; Tzur-Gilat A; Francastel C; Selig S
    Hum Mol Genet; 2018 Oct; 27(20):3568-3581. PubMed ID: 30010917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Mutation in a Critical Region for the Methyl Donor Binding in DNMT3B Causes Immunodeficiency, Centromeric Instability, and Facial Anomalies Syndrome (ICF).
    Rechavi E; Lev A; Eyal E; Barel O; Kol N; Barhom SF; Pode-Shakked B; Anikster Y; Somech R; Simon AJ
    J Clin Immunol; 2016 Nov; 36(8):801-809. PubMed ID: 27734333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three novel ZBTB24 mutations identified in Japanese and Cape Verdean type 2 ICF syndrome patients.
    Nitta H; Unoki M; Ichiyanagi K; Kosho T; Shigemura T; Takahashi H; Velasco G; Francastel C; Picard C; Kubota T; Sasaki H
    J Hum Genet; 2013 Jul; 58(7):455-60. PubMed ID: 23739126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF).
    Ehrlich M; Jackson K; Weemaes C
    Orphanet J Rare Dis; 2006 Mar; 1():2. PubMed ID: 16722602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and genetic manifestations of immunodeficiency, centromeric instability, and facial anomalies syndrome: a case report and literature review].
    Hu SC; Wang YB; Sun Q; Liu XR; Sun LL; Cui GM
    Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):55-59. PubMed ID: 30630233
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel
    Aminorroaya A; Rayzan E; Shahkarami S; Seyedpour S; Zoghi S; Aryan Z; Somekh I; Rohlfs M; Klein C; Esmaeilzadeh H; Rezaei N
    Endocr Metab Immune Disord Drug Targets; 2023; 23(3):410-415. PubMed ID: 35996251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gene mutations and subtelomeric DNA methylation in immunodeficiency, centromeric instability and facial anomalies syndrome.
    Hu H; Chen C; Shi S; Li B; Duan S
    Autoimmunity; 2019; 52(5-6):192-198. PubMed ID: 31476899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mutation in DNMT3B gene causing ICF1 syndrome in an infant with refractory thrombocytopenia.
    Baris S; Boluk SO
    Clin Immunol; 2023 Nov; 256():109779. PubMed ID: 37741519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel iPSC-based model of ICF syndrome subtype 2 recapitulates the molecular phenotype of ZBTB24 deficiency.
    Lullo V; Cecere F; Batti S; Allegretti S; Morone B; Fioriniello S; Pisapia L; Genesio R; Della Ragione F; Giardino G; Pignata C; Riccio A; Matarazzo MR; Strazzullo M
    Front Immunol; 2024; 15():1419748. PubMed ID: 39040103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.